Skip to main content
. 2020 Sep 23;26(1):e12800. doi: 10.1111/anec.12800

TABLE 3.

Cox regression analysis of the association between PVC burden and complexity and outcomes in two groups

Idiopathic Structural heart disease
Unadjusted Adjusted Unadjusted Adjusted
HR (95% CI) p‐value HR (95% CI) p‐value HR (95% CI) p‐value HR (95% CI) p‐value
All‐cause death
PVC% 0.960 (0.912–1.011) .119 0.944 (0.899–0.992) .023 0.951 (0.905–1.000) .048
PVC% per quartile
Quartile 1 Reference Reference Reference Reference
Quartile 2 1.733 (0.806–3.728) .159 0.629 (80.335–1.181) .149
Quartile 3 2.331 (1.090–4.984) .029 2.288 (1.042–5.026) .039 0.645 (0.351–1.187) .159
Quartile 4 1.247 (0.426–2.553) .611 0.384 (0.191–0.772) .007 0.417 (0.203–0.858) .017
Polymorphic 1.713 (0.952–3.085) .073 1.275 (0.707–2.296) .419
Triplets 1.982 (1.173–3.350) .011 1.289 (0.740–2.245) .370 1.117 (0.702–1.779) .641
NSVT 2.162 (1.149–4.070) .017 1.898 (0.984–3.662) .056 1.033 (0.621–1.717) .902
All‐cause death or CV hospitalizations
PVC% 0.973 (0.931–1.016) .210 0.960 (0.921–1.001) .055
PVC% per quartile
Quartile 1 Reference Reference Reference
Quartile 2 1.659(0.840–3.276) .145 0.594 (0.333–1.062) .079
Quartile 3 1.796 (0.891–3.618) .101 0.572 (0.325–1.007) .053
Quartile 4 1.035 (0.493–2.176) .927 0.462 (0.250–0.856) .014 0.484 (0.257–0.911) .025
Polymorphic 1.785 (1.031–3.093) .039 1.222 (0.679–2.201) .504 1.075 (0.637–1.816) .786
Triplets 1.867 (1.145–3.045) .012 1.004 (0.970–1.040) .498 0.999 (0.651–1.5349 .997
NSVT 1.724 (0.926–3.211) .086 1.006 (0.632–1.603) .980
HF death or HF hospitalizations a
PVC% 0.989 (0.913–1.072) .796
PVC% per quartile
Quartile 1 Reference Reference
Quartile 2 1.345 (0.301–6.014) .698
Quartile 3 1.217 (0.272–5.449) .798
Quartile 4 1.265 (0.282–5.666) .759
Polymorphic 4.086 (0.531–31.47) .176
Triplets 2.757 (0.942–8.069) .064
NSVT 1.620 (0.576–4.551) 0.360
Sudden death or hospitalization due to VA
PVC% 0.817 (0.546–1.220) .323 0.980 (0.872–1.102) .736
PVC% per quartile
Quartile 1 Reference Reference Reference Reference
Quartile 2 0.469 (0.043–5.174) .536 0.246 (0.028–2.204) .210
Quartile 3 1.144 (80.161–8.137) .893 0.223 (0.025–2.004) .181
Quartile 4 0.013 (000–1,209) .459 0.430 (0.078–2.357) .331
Polymorphic 44 (0.025–7,766) .319 1.046 (0.211–5.187) .956
Triplets 2.315 (0.387–13.86) .358 0.188 (0.023–1.524) .117
NSVT 2.498 (0.279–22.41) .413 4.345 (1.037–18.20) .044 3.896 (0.903–16.81) .068

Abbreviations: AF, atrial fibrillation; CV, cardiovascular; LAD, left atrium diameter; LVFS, left ventricular fractional shortening; NSVT, non‐sustained ventricular tachycardia; PVCs, premature ventricular contractions; SV, supraventricular; VA, ventricular arrhythmias.

a

The analysis of the combined outcome of HF death or HF hospitalizations the analysis was only done in the SHD group because there was only 1 event in the idiopathic group. In multivariable analysis, only covariables with a p < .05 in univariable analysis were included (Table S3), respectively: for all‐cause mortality, the covariables included were age, presence of supraventricular runs, presence of episodes of AF, LAD, and LVFS; for the combined outcome of all‐cause mortality and CV hospitalizations, the covariables included were age, gender, presence of episodes AF, LAD, and LVFS; for the combined outcome of sudden death or VA hospitalization, the only significant covariable included was LAD.